Alemtuzumab/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
A [[antineoplastic agent]], of the [[monoclonal antibody]] class, directed against the CDw52 antigen expressed by [[ | A [[antineoplastic agent]], of the [[monoclonal antibody]] class, directed against the CDw52 antigen expressed by [[lymphocyte]]s | ||
Latest revision as of 09:14, 5 February 2009
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
Alemtuzumab [r]: A antineoplastic agent, of the monoclonal antibody class, directed against the CDw52 antigen expressed by lymphocytes